Currently, talking about cannabis it is no longer the taboo it was a few years ago. Although it is still a controlled substance, the accumulation of evidence that proves the therapeutic value associated with this plant has allowed it to begin to be seen in another way. The exhaustive and continuous study of several varieties ofcannabis sativa, of its main components (such as cannabinoids and the terpenes), its therapeutic applications and its benefits (and potential risks) has resulted in an increasing acceptance by society.
This led the United Nations to change the classification of cannabis, which moved from Annex IV of the 1961 Single Convention on Narcotic Drugs (a classification that does not recognize the therapeutic value of the substances that are part of it, and wherecannabis sativawas for 59 years) for Annex I (which already recognizes the therapeutic value of the substances that are part of it). This means that access to this plant for medical purposes and R&D will be facilitated, with the expectation that this situation will lead not only to more research on this plant (which will allow us to better understand how its components interact with ours endocannabinoid system, which will lead to a better understanding of the potential benefits and risks associated with its consumption), as well as to a greater development of new therapeutic applications. All of this should contribute so that society has easier access to products based on this plant and can thus enjoy its various health benefits.
To learn more about cannabis, its history, its main components and its therapeutic applications, explore this page.